We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.76B
AUM Growth
-$525M
Cap. Flow
-$439M
Cap. Flow %
-15.9%
Top 10 Hldgs %
38.29%
Holding
343
New
69
Increased
54
Reduced
100
Closed
111

Top Buys

Rank Stock Value
1
VRAY
ViewRay, Inc.
VRAY
+$17.9M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$17.3M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$14.1M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$14M
5
CUTR
Cutera, Inc.
CUTR
+$12.7M

Top Sells

Rank Stock Value
1
SEER icon
Seer Inc
SEER
+$24.7M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.4M
3
LIVN icon
LivaNova
LIVN
+$20.2M
4
GKOS icon
Glaukos
GKOS
+$17.5M
5
COO icon
Cooper Companies
COO
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 29.75%
2 Consumer Staples 0.58%
3 Financials 0.5%
4 Consumer Discretionary 0.42%
5 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
251
PUT
CVS Health
CVS
$121B
– –
-150,000
Closed -$12.7M
DH icon
252
Definitive Healthcare
DH
$69.4M
– –
-100,000
Closed -$4.28M
DNA icon
253
Ginkgo Bioworks
DNA
$486M
– –
-18,750
Closed -$8.69M
EDIT icon
254
CALL
Editas Medicine
EDIT
$436M
– –
-48,900
Closed -$2.01M
EDIT icon
255
Editas Medicine
EDIT
$436M
– –
-10,000
Closed -$411K
EDIT icon
256
PUT
Editas Medicine
EDIT
$436M
– –
-50,000
Closed -$2.05M
EVH icon
257
CALL
Evolent Health
EVH
$471M
– –
-221,300
Closed -$6.86M
EVH icon
258
Evolent Health
EVH
$471M
– –
-275,000
Closed -$8.53M
KYNB
259
Kyntra Bio
KYNB
$28.7M
– –
-1,395
Closed -$356K
FHTX icon
260
Foghorn Therapeutics
FHTX
$394M
– –
-68,095
Closed -$949K
FLGT icon
261
PUT
Fulgent Genetics
FLGT
$515M
– –
-100,000
Closed -$8.99M
FOLD
262
CALL
DELISTED
Amicus Therapeutics
FOLD
– –
-196,800
Closed -$1.88M
GDX icon
263
PUT
VanEck Gold Miners ETF
GDX
$27.8B
– –
-100,000
Closed -$7.28M
GH icon
264
PUT
Guardant Health
GH
$22.2B
– –
-174,000
Closed -$21.8M
GILD icon
265
CALL
Gilead Sciences
GILD
$168B
– –
-150,000
Closed -$10.5M
GKOS icon
266
Glaukos
GKOS
$11B
– –
-378,638
Closed -$17.5M
GNLN icon
267
Greenlane Holdings
GNLN
$1.19M
– –
0
– -$859K
HAE icon
268
CALL
Haemonetics
HAE
$4.16B
– –
-70,000
Closed -$4.94M
HAE icon
269
Haemonetics
HAE
$4.16B
– –
-130,000
Closed -$9.18M
HUM icon
270
PUT
Humana
HUM
$46.7B
– –
-105,000
Closed -$40.9M
HYFM icon
271
Hydrofarm Holdings
HYFM
$8M
– –
-42,729
Closed -$16.2M
ILMN icon
272
PUT
Illumina
ILMN
$29.1B
– –
-77,100
Closed -$30.4M
INCY icon
273
PUT
Incyte
INCY
$24.5B
– –
-30,000
Closed -$2.06M
IONS icon
274
PUT
Ionis Pharmaceuticals
IONS
$9.39B
– –
-10,500
Closed -$352K
IRTC icon
275
iRhythm Holdings
IRTC
$4.13B
– –
-130,000
Closed -$11.9M
9 10
11
12 13

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Pura Vida Investments held 343 positions worth $2.76B, down 16% from $3.29B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $439M in Q4 2021, closing 111 positions and reducing 100 holdings. Its most notable exit was Seer Inc, an estimated $24.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Pura Vida Investments opened a new position in BioMarin Pharmaceuticals worth $15M.

  • Pura Vida Investments's largest Q4 2021 buy was BioMarin Pharmaceuticals: 170,210 shares worth $15M.
  • Pura Vida Investments added most to ViewRay, Inc. in Q4 2021, an estimated $17.9M increase.
  • Pura Vida Investments's biggest Q4 2021 reduction was LivaNova, cutting an estimated $20.2M.
  • Pura Vida Investments fully exited Seer Inc in Q4 2021, selling an estimated $24.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $2.76B portfolio in Q4 2021.
  • Pura Vida Investments opened 69 new positions and closed 111 in Q4 2021.
  • Pura Vida Investments's portfolio value fell 16% quarter-over-quarter to $2.76B.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.